Janssen is recommending physicians withhold prescribing its pulmonary arterial hypertension drug because Philips Respironics is discontinuing the only approved delivery system for the drug.

Mark Cuban Cost Plus Drug Co. is teaming up with PharmcoRx, a pharmacy services business, to expand its pharmacy affiliate network. 

West Reading, Pa.-based Reading Hospital is planning to open a full-service retail pharmacy Nov. 29 in Wyomissing, Pa., according to Lehigh Valley Business.

Antiseizure medications made of levetiracetam and clobazam might cause a rash that can quickly injure organs and hospitalize patients, the FDA said Nov. 28. 

A popular class of Type 2 diabetes and weight management drugs is gaining the attention of women going through menopause who want to lose weight, The New York Times reported Nov. 27.

The FDA approved Ogsiveo (nirogacestat), the first drug indicated for locally aggressive, noncancerous tumors, on Nov. 27. 

Mark Cuban Cost Plus Drug Co. has partnered with digital health company Expion Health in an effort to tackle the rising costs of specialty drugs.

Genesis Medical Center-Dewitt, a MercyOne-owned hospital in Iowa, bought a local pharmacy to include in its network, Our Quad Cities reported Nov. 27. 

Eli Lilly's Mounjaro helped patients lose weight more effectively than Novo Nordisk's Ozempic, according to a preprint study that included more than 40,000 patients. 

Exela Pharma Sciences, an injectable drug company, is recalling more than 415,000 drug vials in a Class I recall because of a possible presence of silicone, according to the FDA.